Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

298 Views

047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Treatment

(506) Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Kristen Andreatta, MS

Research Scientist
Gilead Sciences, Inc.
Foster City, CA, United States

JL

Jiani Li, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Lauren Rodriguez, PhD

Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
SX

Simin Xu, MS

Gilead Sciences, Inc.
Foster City, California, United States
JP

Jason K. Perry, PhD

Gilead Sciences, Inc.
Foster City, California, United States
YK

Yiannis Koullias, MD

Gilead Sciences, Inc.
Foster City, California, United States
RH

Robert H. Hyland, DPhil

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States